RBC Capital reiterates Corteva stock rating ahead of Vylor spin
RBC Capital reiterated an Outperform rating and $103 price target for Corteva (CTVA) ahead of its Vylor spin-off. The firm sees the stock's weakness as an entry point, with a 13x 2027 EBITDA multiple. Corteva's market cap is $55.3B, and it trades at 13.6x EV/EBITDA. RBC maintained FY2026 and FY2027 EBITDA estimates at $4.2B and $4.5B, respectively. UBS and BMO also adjusted their price targets, with UBS citing growth outlook and BMO highlighting EBITDA expectations.
How this was made
The 30-second read
Why it matters
The reiteration reinforces existing expectations but does not introduce new material information.
Market read
Analyst rating repeat offers limited new trading insight; focus remains on upcoming spin-off.
What to watch
Potential valuation gap if Vylor spin creates separate growth narrative.
Background
RBC Capital maintains its Outperform rating and $103 target as Corteva prepares to spin off its seed business, Vylor, on Oct 1.
Ticker impact
RBC Capital reiterated an Outperform rating and $103 price target ahead of Corteva's Vylor spin-off.
Potential modest upside if investors follow the target.
Rating is a repeat, not a new catalyst, limiting impact.
Market effects
Agriculture sector may see modest attention due to Corteva's spin-off.
U.S. agribusiness investors could adjust exposure.
Limited global impact beyond Corteva.
Counterpoint
Rating reiteration may already be priced in, limiting upside.
Key entities
- CompanyCorteva Inc.
Agricultural chemicals and seed producer.
- Research FirmRBC Capital
Equity research analyst firm providing the rating.
